发明名称 Treatment of lung cells with histone deacetylase inhibitors
摘要 Lung disease, such as cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), asthma or acute and chronic bronchitis, can be treated with an oxyamide-containing compound.
申请公布号 US9486421(B2) 申请公布日期 2016.11.08
申请号 US200712003511 申请日期 2007.12.26
申请人 ERRANT GENE THERAPEUTICS, LLC 发明人 Lan-Hargest Hsuan-Yin
分类号 C07C57/60;C07C259/06;C07D307/54;A61K31/16;A61K31/19;C07C57/42 主分类号 C07C57/60
代理机构 Steptoe & Johnson LLP 代理人 Steptoe & Johnson LLP
主权项 1. A method of inhibiting sodium ion transport in an airway epithelial cell comprising contacting the cell with a compound including a zinc-binding moiety in an amount effective to inhibit sodium ion transport and to inhibit a histone deacetylase in a cell, wherein the compound includes an oxyamide linkage and a C4-10 hydrocarbon chain containing at least two carbon-carbon double bonds and wherein the compound is of formula (I)wherein A is a cyclic moiety selected from the group consisting of aryl, or heteroaryl Y1 is —CH2—, —O—, —N(Ra)—, or a bond, and Y2 is —CH2—, —O—, or —N(Rc)—; each of Ra and Rc, independently, being hydrogen, alkyl, alkenyl, alkynyl, alkoxy, hydroxylalkyl, hydroxyl, or haloalkyl; L is the C4-10 hydrocarbon chain containing at least two carbon-carbon double bonds: R1 is hydrogen; R2 is hydrogen; and each of X1 and X2, independently, is —O—; or a pharmaceutically acceptable salt thereof,in an amount effective to inhibit sodium ion transport.
地址 Chicago IL US